We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$17.5B
AUM Growth
+$1.09B
Cap. Flow
+$196M
Cap. Flow %
1.12%
Top 10 Hldgs %
22.04%
Holding
1,814
New
115
Increased
670
Reduced
633
Closed
80

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$41.9M
2
DLB icon
Dolby
DLB
+$23M
3
TDOC icon
Teladoc Health
TDOC
+$20.9M
4
CPRT icon
Copart
CPRT
+$20.8M
5
DXCM icon
DexCom
DXCM
+$16M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Healthcare 17.89%
3 Financials 12.54%
4 Consumer Discretionary 10.12%
5 Industrials 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
176
Vanguard S&P 500 ETF
VOO
$1.03T
$19M 0.11%
69,987
-3,917
-5% -$1.04M
SGEN
177
DELISTED
Seagen Inc. Common Stock
SGEN
$18.8M 0.11%
271,103
+10,497
+4% +$735K
BLK icon
178
Blackrock
BLK
$178B
$18.5M 0.11%
39,459
+636
+2% +$288K
MCHP icon
179
Microchip Technology
MCHP
$44B
$18.5M 0.11%
426,540
+34,800
+9% +$1.55M
EMR icon
180
Emerson Electric
EMR
$91.7B
$18.3M 0.1%
274,947
+41,292
+18% +$2.77M
BDX icon
181
Becton Dickinson
BDX
$49.4B
$18.3M 0.1%
74,583
-5,642
-7% -$1.31M
KO icon
182
Coca-Cola
KO
$372B
$18.2M 0.1%
358,124
+2,184
+0.6% +$107K
EEM icon
183
iShares MSCI Emerging Markets ETF
EEM
$29.9B
$18.1M 0.1%
422,360
+50,676
+14% +$2.15M
SHAK icon
184
Shake Shack
SHAK
$2.9B
$18.1M 0.1%
250,675
-293
-0.1% -$18.1K
AZN icon
185
AstraZeneca
AZN
$246B
$17.8M 0.1%
215,390
+13,515
+7% +$1.06M
TD icon
186
Toronto Dominion Bank
TD
$201B
$17.8M 0.1%
304,548
+3,280
+1% +$184K
XYZ
187
Block Inc
XYZ
$47.5B
$17.7M 0.1%
243,497
+40,118
+20% +$2.8M
YETI icon
188
Yeti Holdings
YETI
$3.85B
$17.5M 0.1%
605,977
+22,148
+4% +$638K
PM icon
189
Philip Morris
PM
$290B
$17.3M 0.1%
220,420
-7,071
-3% -$584K
AXDX
190
DELISTED
Accelerate Diagnostics
AXDX
$17.3M 0.1%
75,630
+6,178
+9% +$1.21M
WST icon
191
West Pharmaceutical
WST
$24.7B
$17M 0.1%
135,879
-6,031
-4% -$712K
DEO icon
192
Diageo
DEO
$52.8B
$17M 0.1%
98,462
+2,694
+3% +$453K
NVS icon
193
Novartis
NVS
$294B
$16.9M 0.1%
185,489
-15,325
-8% -$1.3M
HLT icon
194
Hilton Worldwide
HLT
$70.8B
$16.8M 0.1%
172,194
+1,201
+0.7% +$109K
VOE icon
195
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$16.7M 0.1%
149,547
+12,333
+9% +$1.35M
APD icon
196
Air Products & Chemicals
APD
$68.9B
$16.5M 0.09%
72,850
+1,184
+2% +$245K
QCOM icon
197
Qualcomm
QCOM
$171B
$16.4M 0.09%
215,893
+3,035
+1% +$222K
QTWO icon
198
Q2 Holdings
QTWO
$3.95B
$16.3M 0.09%
+213,468
New +$15.4M
FLRN icon
199
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
$16.2M 0.09%
528,500
+13,510
+3% +$415K
CAT icon
200
Caterpillar
CAT
$388B
$16.2M 0.09%
119,136
+4,337
+4% +$573K

Similar funds

William Blair & Company's Q2 2019 Portfolio in Review

As of Q2 2019, William Blair & Company held 1,814 positions worth $17.5B, up 6.6% from $16.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

William Blair & Company's Q2 2019 filing shows 115 new, 670 increased, 633 reduced and 80 closed positions. Its largest new stake was Q2 Holdings: 213,468 shares worth $16.3M. The largest sale was Red Hat Inc, an estimated $144M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2019 buy was Q2 Holdings: 213,468 shares worth $16.3M.
  • William Blair & Company added most to Fiserv Inc in Q2 2019, an estimated $41.9M increase.
  • William Blair & Company's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $16.4M.
  • William Blair & Company fully exited Red Hat Inc in Q2 2019, selling an estimated $144M.
  • William Blair & Company's ten largest holdings make up 22% of its $17.5B portfolio in Q2 2019.
  • William Blair & Company opened 115 new positions and closed 80 in Q2 2019.
  • William Blair & Company's portfolio value rose 6.6% quarter-over-quarter to $17.5B.

Based on William Blair & Company's 13F filing for Q2 2019, filed 13 Aug 2019.